495 related articles for article (PubMed ID: 33894500)
1. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
[TBL] [Abstract][Full Text] [Related]
2. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
[TBL] [Abstract][Full Text] [Related]
3.
Maurya AK; Mishra N
J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
[TBL] [Abstract][Full Text] [Related]
4. Screening of natural compounds from Cyperus rotundus Linn against SARS-CoV-2 main protease (M
Kumar SB; Krishna S; Pradeep S; Mathews DE; Pattabiraman R; Murahari M; Murthy TPK
Comput Biol Med; 2021 Jul; 134():104524. PubMed ID: 34090015
[TBL] [Abstract][Full Text] [Related]
5. Targeting COVID-19 (SARS-CoV-2) main protease through active phytochemicals of ayurvedic medicinal plants -
Shree P; Mishra P; Selvaraj C; Singh SK; Chaube R; Garg N; Tripathi YB
J Biomol Struct Dyn; 2022 Jan; 40(1):190-203. PubMed ID: 32851919
[TBL] [Abstract][Full Text] [Related]
6. Protein reliability analysis and virtual screening of natural inhibitors for SARS-CoV-2 main protease (M
Kapusta K; Kar S; Collins JT; Franklin LM; Kolodziejczyk W; Leszczynski J; Hill GA
J Biomol Struct Dyn; 2021 Oct; 39(17):6810-6827. PubMed ID: 32795148
[TBL] [Abstract][Full Text] [Related]
7. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
[TBL] [Abstract][Full Text] [Related]
8. An efficient eco-friendly, simple, and green synthesis of some new spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives as potential inhibitors of SARS-CoV-2 proteases: drug-likeness, pharmacophore, molecular docking, and DFT exploration.
El-Saghier AM; Enaili SS; Abdou A; Kadry AM
Mol Divers; 2024 Feb; 28(1):249-270. PubMed ID: 37946070
[TBL] [Abstract][Full Text] [Related]
9. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
Hicks EG; Kandel SE; Lampe JN
Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
[TBL] [Abstract][Full Text] [Related]
10. Molecular Docking, ADMET Analysis and Molecular Dynamics (MD) Simulation to Identify Synthetic Isoquinolines as Potential Inhibitors of SARS-CoV-2 M
Dos Santos Correia PR; de Souza AHD; Chaparro AR; Tenorio Barajas AY; Porto RS
Curr Comput Aided Drug Des; 2023; 19(5):391-404. PubMed ID: 36694326
[TBL] [Abstract][Full Text] [Related]
11. In silico molecular docking: Evaluation of coumarin based derivatives against SARS-CoV-2.
Chidambaram SK; Ali D; Alarifi S; Radhakrishnan S; Akbar I
J Infect Public Health; 2020 Nov; 13(11):1671-1677. PubMed ID: 33008777
[TBL] [Abstract][Full Text] [Related]
12. Molecular docking and simulation studies of natural compounds of
Mitra D; Verma D; Mahakur B; Kamboj A; Srivastava R; Gupta S; Pandey A; Arora B; Pant K; Panneerselvam P; Ghosh A; Barik DP; Mohapatra PKD
J Biomol Struct Dyn; 2022 Aug; 40(12):5665-5686. PubMed ID: 33459176
[TBL] [Abstract][Full Text] [Related]
13. The inhibitory effect of some natural bioactive compounds against SARS-CoV-2 main protease: insights from molecular docking analysis and molecular dynamic simulation.
Abdelrheem DA; Ahmed SA; Abd El-Mageed HR; Mohamed HS; Rahman AA; Elsayed KNM; Ahmed SA
J Environ Sci Health A Tox Hazard Subst Environ Eng; 2020; 55(11):1373-1386. PubMed ID: 32998618
[TBL] [Abstract][Full Text] [Related]
14. In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2.
Khan S; Nasrullah ; Hussain A; Asif M; Sattar FA; Audhal FA; Qadir MI; Hamdard MH
Medicine (Baltimore); 2023 Feb; 102(6):e31318. PubMed ID: 36820539
[TBL] [Abstract][Full Text] [Related]
15. In-Silico approach for identification of effective and stable inhibitors for COVID-19 main protease (M
Das P; Majumder R; Mandal M; Basak P
J Biomol Struct Dyn; 2021 Oct; 39(16):6265-6280. PubMed ID: 32705952
[TBL] [Abstract][Full Text] [Related]
16. Virtual screening of phytochemicals by targeting multiple proteins of severe acute respiratory syndrome coronavirus 2: Molecular docking and molecular dynamics simulation studies.
Azeem M; Mustafa G; Mahrosh HS
Int J Immunopathol Pharmacol; 2022; 36():3946320221142793. PubMed ID: 36442514
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease.
C S; S DK; Ragunathan V; Tiwari P; A S; P BD
J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178
[TBL] [Abstract][Full Text] [Related]
18. Virtual Screening of Natural Products against Type II Transmembrane Serine Protease (TMPRSS2), the Priming Agent of Coronavirus 2 (SARS-CoV-2).
Rahman N; Basharat Z; Yousuf M; Castaldo G; Rastrelli L; Khan H
Molecules; 2020 May; 25(10):. PubMed ID: 32408547
[TBL] [Abstract][Full Text] [Related]
19. Putative SARS-CoV-2 M
Mazzini S; Musso L; Dallavalle S; Artali R
Molecules; 2020 Aug; 25(16):. PubMed ID: 32824454
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Diverse Natural Products as Inhibitors of SARS-CoV-2 M
Rubio-Martínez J; Jiménez-Alesanco A; Ceballos-Laita L; Ortega-Alarcón D; Vega S; Calvo C; Benítez C; Abian O; Velázquez-Campoy A; Thomson TM; Granadino-Roldán JM; Gómez-Gutiérrez P; Pérez JJ
J Chem Inf Model; 2021 Dec; 61(12):6094-6106. PubMed ID: 34806382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
